Sofinnova Investments’s Merck MRK Stock Holding History

Sofinnova Investments’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-300,000	Closed	-$25.8M	–	61
2022 Q3	$25.8M	Buy	+300,000	New	+$26.8M	1.5%	16
2021 Q4	–	Sell	-600,000	Closed	-$45.1M	–	77
2021 Q3	$45.1M	Buy	+600,000	New	+$45.6M	2.67%	8

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sofinnova Investments's MRK Position: Q2 2024 in Review

Sofinnova Investments sold out of Merck (MRK) in Q2 2024, closing a stake of 651,299 shares — an estimated $85.9M sold.

Sofinnova Investments first reported a position in MRK in Q4 2019 and held it in 12 quarters. The position peaked at $93.5M in Q4 2023. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

Sofinnova Investments reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
Sofinnova Investments sold 651,299 Merck shares in Q2 2024, an estimated $85.9M.
Sofinnova Investments first reported a position in Merck in Q4 2019 and held it in 12 quarters.
Sofinnova Investments's Merck position peaked at $93.5M in Q4 2023.
3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Sofinnova Investments's 13F filing for Q2 2024, filed 9 Aug 2024.